Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing

Pain

Volumn 80, Issue 1-2, 1999, Pages 57-65

  Martin, William J ^a,b   Gupta, Neel K ^a   Loo, Carole M ^a   Rohde, Dana S ^a   Basbaum, Allan I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immunotoxin; Locus coeruleus; Morphine; Nociception; Saporin

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; IMMUNOTOXIN; MORPHINE; SAPORIN;

ANIMAL EXPERIMENT; BEHAVIOR; CONTROLLED STUDY; HYPERALGESIA; IMMUNOCHEMISTRY; INTRATHECAL DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; NOCICEPTION; NONHUMAN; NORADRENERGIC SYSTEM; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; REVIEW; SPINAL CORD DORSAL HORN; TAIL FLICK TEST;

EID: 0033061299     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00194-8     Document Type: Article

References (53)

1. Basbaum, A.I., Anatomical studies of the noradrenergic projection to the spinal cord dorsal horn. In: J.M. Besson and G. Guilbaud (Eds.), Towards the Use of Noradrenergic Agonists For the Treatment of Pain, Excerpta Medica, Amsterdam, 1992, pp. 77-89.
2. Basbaum, A.I. and Fields, H.L., Endogenous pain control mechanisms: review and hypothesis, Ann. Neurol., 4 (1978) 451-462.
3. Basbaum, A.I. and Fields, H.L., Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry, Annu. Rev. Neurosci., 7 (1984) 309-338.
4. Berge, O.G. and Ogren, S.O., Limited involvement of central noradrenergic pathways in morphine-induced antinociception, Neuropharmacology, 23 (1984) 1179-1185.
5. Burnett, A. and Gebhart, G.F., Characterization of descending modulation of nociception from the A5 cell group, Brain Res., 546 (1991) 271-281.
6. Clark, F.M. and Proudfit, H.K., The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception, Brain Res., 616 (1993) 200-210.
7. Dubuisson, D. and Dennis, S.G., The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats, Pain, 4 (1977) 161-174.
8. Fasmer, O.B., Berge, O.G., Tveiten, L. and Hole, K., Changes in nociception after 6-hydroxydopamine lesions of descending catecholaminergic pathways in mice., Pharmacol. Biochem. Behav., 24 (1986) 1441-1444.
9. Fields, H.L., Heinricher, M.M. and Mason, P., Neurotransmitters in nociceptive modulatory circuits, Annu. Rev. Neurosci., 14 (1991) 219-245.
10. Fritschy, J.-M. and Grzanna, R., Demonstration of two separate descending noradrenergic pathways to the rat spinal cord: evidence for an intragriseal trajectory of locus coeruleus axons in the superficial layers of the dorsal horn, J. Comp. Neurol., 291 (1990) 553-582.
11. Fritschy, J.-M., Lyons, W.E., Mullen, C.A., Kosofsky, B.E., Molliver, M.E. and Grzanna, R., Distribution of locus coeruleus axons in the rat spinal cord: a combined anterograde transport and immunohistochemical study, Brain Res., 437 (1987) 176-180.
12. Fritschy, J.M. and Grzanna, R., Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system? Prog. Brain Res., 88 (1991) 257-268.
13. Hallman, H., Sundstrom, E. and Jonsson, G., Effects of the noradrenaline neurotoxin DSP 4 on monoamine neurons and their transmitter turnover in rat CNS, J. Neural Transm., 60 (1984) 89-102.
14. Hammond, D.L., Levy, R.A. and Proudfit, H.K., Hypoalgesia following microinjection of noradrenergic antagonists in the nucleus raphe magnus, Pain, 9 (1980) 85-101.
15. Hammond, D.L. and Proudfit, H.K., Effects of locus coeruleus lesions on morphine-induced antinociception, Brain Res., 188 (1980) 79-91.
16. Hodge, C.J. Jr., Apkarian, A.V., Stevens, R.T., Vogelsang, G.D., Brown, O. and Franck, J.I., Dorsolateral pontine inhibition of dorsal horn cell responses to cutaneous stimulation: lack of dependence on catecholaminergic systems in cat, J. Neurophysiol., 50 (1983) 1220-1235.
17. Howe, J.R., Wang, J.Y. and Yaksh, T.L., Selective antagonism of the antinociceptive effect of intrathecally applied alpha adrenergic agonists by intrathecal prazosin and intrathecal yohimbine, J. Pharmacol. Exp. Ther., 224 (1983) 552-558.
18. Hsu, S.-M. and Raine, L., Protein A, avidin, and biotin in immuno-cytochemistry, J. Histochem. Cytochem., 29 (1981) 1349-1353.
19. Jones, S.L., Descending noradrenergic influences on pain, Prog. Brain Res., 88 (1991) 381-394.
20. Jones, S.L. and Gebhart, G.F., Characterization of coeruleospinal inhibition of the nociceptive tail- flick reflex in the rat: mediation by spinal alpha 2-adrenoceptors, Brain Res., 364 (1986) 315-330.
21. Kuraishi, Y., Harada, Y., Aratani, S., Satoh, M. and Takagi, H., Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests, Brain Res., 273 (1983) 245-252.
22. Kuraishi, Y., Harada, Y. and Takagi, H., Noradrenaline regulation of pain-transmission in the spinal cord mediated by alpha-adrenoceptors, Brain Res., 174 (1979) 333-336.
23. Kuraishi, Y., Satoh, M. and Takagi, H., The descending noradrenergic system and analgesia, Pain Headache, 9 (1987) 101-128.
24. Kwiat, G.C. and Basbaum, A.I., The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn in the rat, Somatosens. Mot. Res., 9 (1992) 157-173.
25. Llewellyn-Smith, I.J. and Minson, J.B., Complete penetration of antibodies into vibratome sections after glutaraldehyde fixation and ethanol treatment: light and electron microscopy for neuropeptides, J. Histochem. Cytochem., 40 (1992) 1741-1749.
26. Lyons, W.E., Fritschy, J.M. and Grzanna, R., The noradrenergic neurotoxin DSP-4 eliminates the coeruleospinal projection but spares projections of the A5 and A7 groups to the ventral horn of the rat spinal cord, J. Neurosci., 9 (1989) 1481-1489.
27. Mestre, C., Pelissier, T., Fialip, J., Wilcox, G. and Eschalier, A., A method to perform direct transcutaneous intrathecal injections in rats, J. Pharmacol. Toxicol. Meth., 32 (1994) 197-200.
28. Mokha, S.S., McMillan, J.A. and Iggo, A., Descending control of spinal nociceptive transmission. Actions produced on spinal multireceptive neurones from the nuclei locus coeruleus (LC) and raphe magnus (NRM), Exp. Brain Res., 58 (1985) 213-226.
29. Nygren, L.G. and Olson, L., A new major projection from locus coeruleus: the main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord, Brain Res., 132 (1977) 85-93.
30. Ossipov, M.H., Chatterjee, T.K. and Gebhart, G.F., Locus coeruleus lesions in the rat enhance the antinociceptive potency of centrally administered clonidine but not morphine, Brain Res., 341 (1985) 320-330.
31. Picklo, M.J., Wiley, R.G., Lappi, D.A. and Robertson, D., Noradrenergic lesioning with an anti-dopamine beta-hydroxylase immunotoxin, Brain Res., 666 (1994) 195-200.
32. Proudfit, H.K. and Clark, F.M., The projections of locus coeruleus neurons to the spinal cord, Prog. Brain Res., 88 (1991) 123-1-41.
33. Proudfit, H.K. and Hammond, D.L., Alterations in nociceptive threshold and morphine-induced analgesia produced by intrathecally administered amine antagonists, Brain Res., 218 (1981) 393-399.
34. Ren, K. and Dubner, R., Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation, J. Neurophysiol., 76 (1996) 3025-3037.
35. Ren, K. and Ruda, M.A., Descending modulation of Fos expression after persistent peripheral inflammation, NeuroReport, 7 (1996) 2186-2190.
36. Rohde, D.S. and Basbaum, A.B., Appearance of novel behaviors and increased spinal cord fos expression when withdrawal is precipitated in rats with lesions of the locus coeruleus, J. Neurosci., (1998) in press.
37. Sagen, J., Winker, M.A. and Proudfit, H.K., Hypoalgesia induced by the local injection of phentolamine in the nucleus raphe magnus: blockade by depletion of spinal cord monoamines, Pain, 16 (1983) 253-263.
38. Satoh, K., Tohyama, M., Yamamoto, K., Sakumoto, T. and Shimizu, N., Noradrenaline innervation of the spinal cord studied by the horseradish peroxidase method combined with monoamine oxidase staining, Exp. Brain. Res., 30 (1977) 175-186.
39. Sawynok, J., The 1988 Merck Frosst Award. The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies, Can. J. Physiol. Pharmacol., 67 (1989) 975-988.
40. Sawynok, J. and Reid, A., Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia, Brain Res., 419 (1987) 156-165.
41. Sawynok, J., Reid, A.R. and Doak, G.J., Caffeine antinociception in the rat hot-plate and formalin tests and locomotor stimulation: involvement of noradrenergic mechanisms, Pain, 61 (1995) 203-213.
42. Schaible, H.G., Neugebauer, V., Cervero, F. and Schmidt, R.F., Changes in tonic descending inhibition of spinal neurons with articular input during the development of acute arthritis in the cat, J. Neurophysiol., 66 (1991) 1021-1032.
43. Tjolsen, A., Berge, O.G. and Hole, K., Lesions of bulbo-spinal serotonergic or noradrenergic pathways reduce nociception as measured by the formalin test, Acta Physiol. Scand., 142 (1991) 229-236.
44. Tjolsen, A., Lund, A. and Hole, K., The role of descending noradrenergic systems in regulation of nociception: the effects of intrathecally administered alpha-adrenoceptor antagonists and clonidine, Pain, 43 (1990) 113-120.
45. Tsuruoka, M. and Willis, W.D.J., Bilateral lesions in the area of the nucleus locus coeruleus affect the development of hyperalgesia during carrageenan-induced inflammation, Brain Res., 726 (1996) 233-236.
46. West, W.L., Yeomans, B.C. and Proudfit, H.K., The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats, Brain Res., 626 (1993) 127-135.
47. Westlund, K.N., Bowker, R.M., Ziegler, M.G. and Coulter, J.D., Origins of spinal noradrenergic pathways demonstrated by retrograde transport of antibody to dopamine-beta-hydroxylase, Neurosci Lett., 25 (1981) 243-249.
48. Westlund, K.N., Bowker, R.M., Ziegler, M.G. and Coulter, J.D., Noradrenergic projections to the spinal cord of the rat, Brain Res., 263 (1983) 15-31.
49. Wigdor, S. and Wilcox, G.L., Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways, J. Pharmacol. Exp. Ther., 242 (1987) 90-95.
50. Wrenn, C.C., Picklo, M.J., Lappi, D.A., Robertson, D. and Wiley, R.G., Central noradrenergic lesioning using anti-DβH-saporin: anatomical findings, Brain Res., 740 (1996) 175-184.
51. Yaksh, T.L., Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing, Pharmacol. Biochem. Behav., 22 (1985) 845-858.
52. Yeomans, B.C., Clark, F.M., Paice, J.A. and Proudfit, H.K., Antinociception induced by electrical stimulation of spinally projecting noradrenergic neurons in the A7 catecholamine cell group of the rat, Pain, 48 (1992) 449-461.
53. Zhong, F.X., Ji, X.Q. and Tsou, K., Intrathecal DSP4 selectively depletes spinal noradrenaline and attenuates morphine analgesia, Eur. J. Pharmacol., 116 (1985) 327-330.